Gone in a Heartbeat…. Course in the Wards 1 st Hospital Day 6/10 R occipital headache 107/59, 110, 18, 37.4 degrees C.

Slides:



Advertisements
Similar presentations
Valvular Heart Disease
Advertisements

Regurgitant Systolic Murmurs Chapter 15
RET 1024 Introduction to Respiratory Therapy
1. CARDIOVASCULAR SYSTEM CARDIAC CYCLE HEART SOUNDS LECTURE – 4 DR. ZAHOOR ALI SHAIKH 2.
PHYSICAL EXAMINATION OF THE HEART
12.3 ICD Chapter-Specific Guidelines and Format for the Circulatory System The most common cardiovascular system problems are chest pain, hypertension.
Cardiac Murmurs Lubna Piracha, D.O. Assistant Professor of Medicine Department of Cardiology.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Initial Resting Assessments Blood Pressure, Heart Rate, Cholesterol.
HEART SOUNDS.
Ass. Professor of Cardiology
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
Cardiovascular Examination Dr. Aisha AL-Ghamdi Associate professor Consultant internist.
Mitral stenosis. Case history #1 A 52-year-old woman presents with gradually increasing dyspnoea on exertion over the past 2 years. Recently she has required.
Timothy P. Morris, D.O., F.A.C.C.
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
Valvular heart disease Mitral Valve Diseases
Aetiology * MVP { Myxomatous mv },commonest in developed world *Damage to the cusps : _RVD _ IE _ Congenital Cleft MV *Damage to chordae : _RVD.
Common Clinical Scenarios *Younger people *Younger people _Functional murmur vs _Functional murmur vs _ MVP vs _ MVP vs _ AS _ AS *Older people _Aortic.
Cardiovascular Problems
Chapter 8: The Cardiovascular System Dr. Felix Hernandez M.D.
RJS Valvular heart disease Richard Schilling St Mary’s Hospital London.
Valvular Heart DISEASE
Mitral Valve Disease Prof JD Marx UFS January 2006.
Autotransplantation as a Method for Treatment of a Giant Left Atrium Mitrev Z, Anguseva T, Vogt P Cardiosurgery - Skopje Special hospital for Cardiosurgery.
Valvular Heart Disease Mitral Stenosis
 Aortic stenosis  Heart failure  Dr.Aso faeq salih.
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
Common diseases of the heart and circulatory system
CV 3: Valvular Heart Disease Lab September 19, 2011.
ACSM’s Guidelines For Exercise Testing And Prescription : Chapter 3 Pretest Clinical Evaluation David Arnall, Ph.D., P.T., FACSM, ES.
Rheumatic Heart Disease Definition: streptococcal infection. children Pathology: - Anti-gen antibody reaction mediate inflammation. - * Clinical.
MITRAL VALVE DISEASES. MITRAL VALVE DISEASES 1. Mitral valve stenosis. 2. Mitral valve regurge. 3. Mitral valve prolapse.
ANCILLARY PROCEDURES. 11/23/0911/28/09 UnitNV Hgb g/L RBC X10^12/L Hct MCV U^ MCH
HEART DISEASE IN PREGNANCY. The incidence of cardiac lesion is less than 1% among hospital deliveries. The commonest cardiac lesion is of rheumatic origin.
Adult Medical-Surgical Nursing
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
 28 y/o, Female  Chief Complaint: Dyspnea 3 days PTA Underwent dental procedures 2 days PTA Productive cough with yellowish sputum accompanied by colds.
By Dr. Zahoor 1. Question 1 1. What is the diagnosis? 2.
1 By Dr. Zahoor. Question 1 A 36 year old male patient presents with tiredness, headaches and following is the blood count:  Hb 9.2 g/dl  MCV 109 fl.
By Dr. Zahoor 1. General Examination Examine – patient should be at 450 in bed.  Clubbing of fingers – in relation to the heart suggest infective endocarditis.
Initial Diagnostics CT –Malacic changes, CBC –Hgb 138 –Hct.42 –WBC 8.5 N.72 L.24 M.04 –PC 137 PT 12.2 INR 0.89 ALT (10-40) BUN 4.48 Crea (45-84)
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
THE HEART THE CARDIOVASCULAR SYSTEM. HEART CHAMBERS Atria – two upper chambers (receiving); R & L Ventricles – two lower chambers (discharging); R & L.
ANCILLARY PROCEDURES. Done in the patient CBC Na, K Creatinine SGOT, SGPT 12-L ECG.
ADULT ECHOCARDIOGRAPHY Lesson Nine Valvular Heart Disease
RJS How and why the heart goes wrong. RJS What there is to go wrong.
Cardioembolic Stroke: Diagnosis and Management
Inspection and Palpation of the heart
Mitral valve Stenosis *Read pages 1 – 9 in The Echocardiographer’s Pocket Reference; Read pages 259 – 262 and 277 – 286 in Otto; Read Pages 185 – 190.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Interpreting Laboratory Tests Mesa Community College NUR 152.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for the management of patients.
By Dr. Zahoor DATA INTERPRETATION-2.
Cardiac Cycle and Sounds
Cardiothoracic Surgery
By Dr. Zahoor DATA INTERPRETATION-2.
By Dr. Zahoor DATA INTERPRETATION-2.
Atrial Fibrillation in a CLL Patient Treated with Ibrutinib
Laboratory Diagnostic Testing
Examination of Cardiovascular System
Abnormal Heart Sound Daryl P. Lofaso, M.Ed, RRT
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
Basic laboratory testing
Basic laboratory testing
Interpreting Cardiac Echo Reports
Abnormal Heart Sound Daryl P. Lofaso, M.Ed, RRT
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
Examination of Cardiovascular System
Presentation transcript:

Gone in a Heartbeat…

Course in the Wards

1 st Hospital Day 6/10 R occipital headache 107/59, 110, 18, 37.4 degrees C

1 st Hospital Day CBC Hemoglobin g/L Hematocrit RBC RBC Indices - MCV MCH MCHC RDW-CV WBC Count x 10-9/L Platelet Count x 10-9/L Differential Count - Neutrophils Lymphocytes Monocytes Eosinophils

1 st Hospital Day Bleeding Parameters PT sec INR 1.09 aPTT sec Clotting Time min Bleeding Time min

1 st Hospital Day Electrolytes Sodium meq/L Potassium meq/L

1 st Hospital Day Blood Chemistry SGPT (ALT) V/L Creatinine (Blood) mg/dL Urea Nitrogen mg/dL

Chest Xray No significant findings

ECG Normal sinus rhythm, biatrial enlargement

Normal Basal Ganglia in CT Scan

J.E. CT Scan

Patient’s CT Scan Report Isodense focus in the right capsuloganglionic region Maybe secondary to a mass lesion, less likely a subacute hemorrhage. A contrast enhanced CT or MRI study is suggested Rightward nasal septal deviation.

1 st Hospital Day Assessment: cerebrovacular disease- infarct vs bleed, right middle cerebral artery Plan: Citicoline, Mannitol, Paracetamol To ACSU/ICU

2 nd Hospital Day intermittent HA 3/10 110/60, 90, 20, 37.9C Motor: 3/5 on the left, 5/5 on the right Sensory: 80 % on the left

2 nd Hospital Day Lipid Profile Cholesterol mg/dL HDL Cholesterol mg/dL LDL Cholesterol mg/dL Triglycerides mg/dL VLDL mg/dL Glucose (Fasting) mg/dL

Normal Basal Ganglia in MRI

Patient’s MRI T2 T1

Patient’s MRI FLAIR SWI

Patient’s MRI DWI ADC

Patient’s MRI

Patient’s MRI/MRA Report Acute hemorrhagic infarct, right posterior capsuloganglionic region and corona radiata without significant midline shift Consider a tiny acute non-hemorrhagic infarct in the left extreme capsule No abnormal areas of contrast enhancement No hydrocephalus at this time No obvious aneurysmal dilatation, stenosis, or abnormal tangle of vessels

MRI/MRA Acute hemorrhagic infarct, right posterior capsuloganglionic region and corona radiate without significant midline shift. Consider a tiny acute non-hemorrhagic infarct in the left extreme capsule. No abnormal areas of contrast enhancement. No hydrocephalus at this time. Unremarkable MRA study No obvious aneurismal dilatation, stenosis or abnormal tangle of vessels.

2 nd Hospital Day Assessment: Acute Hemorrhagic Infarct, R, capsuloganglionic region Plan: Secondary Stroke Prevention, Rehab

3 rd Hospital Day 2/10 intermittent HA Motor: 3/5 left, able to move left thumb Sensory: 80% left Referred to cardio due to murmur on pe history of easy fatigability climbing 2 flights of stairs 110/70, 80, 20, afebrile JVP 3cm Apex beat 5 th ICS MCL R Ventricular Heave Palpable Thrill Loud S1 opening snap increased P2 component at least grade 4 Diastolic murmur

Laboratory Findings 8/22/2011 – Electrolytes Potassium meq/L

Laboratory Findings 8/22/2011 – Thyroid Function Test TSH vIU/mL FT pg/mL FT ng/dL

ASO 144 (0-200) ESR 27 (0-20) iCA, Mg – Normal Lipid Profile – Normal ECG – Sinus rhythm

3 rd Hospital Day Assessment: Mitral Stenosis probably secondary to RHD NYHA functional class II Acute Hemorrhagic infarct R capsuloganglionic region Plan: Penicillin 1.2 million units IM Ivabradine 5mg/tab BID as needed

4 th Hospital Day No headache 104/58, 83, 20, afebrile Motor: 4/5 LUE, 3/5 LLE able to move thumb and fingers Sensation: 90% on LUE and LLE

2D ECHO Rheumatic heart disease with severe mitral stenosis, aortic sclerosis, and possible tricuspid sclerosis with moderate-severe tricuspid regurgitation. Pulmonary hypertension Left atrial enlargement with probable atrial thrombi Normal left ventricular size and contractility Estimated systolic pulmonary artery pressure 52mmHg by TR jet

2D ECHO

ECG Atrial fibrillation with moderate to rapid ventricular response

Assesment: Cerebrovascular disease - infarct, right MCA, probably cardioembolic with hemorrhagic conversion Valvular Heart Disease, Dilated left atrium, Severe mitral stenosis, mild tricuspid regurgitation probably secondary to Rheumatic heart disease Paroxysmal Atrial Fibrillation with Rapid Ventricular Response Congestive Heart failure, NYHA Functional Class II Plan: Verapamil, Amiodarone

5 th Hospital Day TEE

Severe mitral stenosis with MVA cm2 mean gradient mmHg Dilated left atrium Positive spontaneous echo contrast, no thrombus visualized Mild tricuspid regurgitation

Assessment: Cerebrovascular disease - infarct, right MCA, probably cardioembolic with hemorrhagic conversion Valvular Heart Disease, Dilated left atrium, Severe mitral stenosis, mild tricuspid regurgitation probably secondary to Rheumatic heart disease Paroxysmal Atrial Fibrillation with Rapid Ventricular Response Congestive Heart failure, NYHA Functional Class II Plan: Atenolol